Glioma-derived versican promotes tumor expansion via glioma-associated microglial/macrophages Toll-like receptor 2 signaling

Neuro-Oncology

Volumn 17, Issue 2, 2015, Pages 200-210

  Hu, Feng ^a,d   Dzaye, Omar Dildar A ^a   Hahn, Alexander ^a   Yu, Yong ^a   Scavetta, Rick Joey ^a   Dittmar, Gunnar ^a   Kaczmarek, Adrian Kamil ^b   Dunning, Kylie R ^b   Ricciardelli, Carmela ^b   Rinnenthal, Jan L ^c   Heppner, Frank L ^c   Lehnardt, Seija ^c   Synowitz, Michael ^c   Wolf, Susanne A ^a   Kettenmann, Helmut ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

glioma; microglia brain macrophages; MT1 MMP; TLR2; versican

Indexed keywords

MATRIX METALLOPROTEINASE 14; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; VERSICAN; CSPG2 PROTEIN, MOUSE; INTERSTITIAL COLLAGENASE; TLR2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN SLICE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MACROPHAGE; MICROGLIA; MOUSE; NONHUMAN; PROTEOMICS; SURVIVAL RATE; UPREGULATION; ANIMAL; BRAIN TUMOR; C57BL MOUSE; GENETICS; KNOCKOUT MOUSE; METABOLISM; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; GLIOMA; HUMANS; MACROPHAGES; MATRIX METALLOPROTEINASE 1; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; SIGNAL TRANSDUCTION; SURVIVAL RATE; TOLL-LIKE RECEPTOR 2; VERSICANS;

EID: 84925010154     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nou324     Document Type: Article

References (35)

1. Charles NA, Holland EC, Gilbertson R, et al. The brain tumor microenvironment. Glia. 2012;60(3):502-514.
2. Badie B, Schartner J. Role of microglia in glioma biology. Microsc Res Tech. 2001;54(2):106-113.
3. Graeber MB, Scheithauer BW, Kreutzberg GW. Microglia in brain tumors. Glia. 2002;40(2):252-259.
4. Markovic DS, Glass R, Synowitz M, et al. Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J Neuropathol Exp Neurol. 2005;64(9): 754-762.
5. Zhai H, Heppner FL, Tsirka SE. Microglia/macrophages promote glioma progression. Glia. 2011;59(3):472-485.
6. Markovic DS, Vinnakota K, Chirasani S, et al. Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion. Proc Natl Acad Sci USA. 2009;106(30):12530-12535.
7. Vinnakota K, Hu F, Ku MC, et al. Toll-like receptor 2 mediates microglia/brain macrophage MT1-MMP expression and glioma expansion. Neuro-Oncol. 2013;15(11):1457-1468.
8. Markovic DS, Vinnakota K, van Rooijen N, et al. Minocycline reduces glioma expansion and invasion by attenuating microglial MT1-MMP expression. Brain Behav Immun. 2011;25(4):624-628.
9. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4(7):499-511.
10. Piccinini AM, Midwood KS. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010;2010:pii:672395.
11. Matzinger P. Tolerance, danger, and the extended family. Ann Rev Immunol. 1994;12:991-1045.
12. Kim S, Takahashi H, Lin WW, et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature. 2009;457(7225):102-106.
13. Naso MF, Zimmermann DR, Iozzo RV. Characterization of the complete genomic structure of the human versican gene and functional analysis of its promoter. J Biol Chem. 1994;269(52): 32999-33008.
14. Wu YJ, La Pierre DP, Wu J, et al. The interaction of versican with its binding partners. Cell Res. 2005;15(7):483-494.
15. Wu Y, Sheng W, Chen L, et al. Versican V1 isoform induces neuronal differentiation and promotes neurite outgrowth. Mol Biol Cell. 2004;15(5):2093-2104.
16. Schmalfeldt M, Bandtlow CE, Dours-Zimmermann MT, et al. Brain derived versican V2 is a potent inhibitor of axonal growth. J Cell Sci. 2000;113(Pt 5):807-816.
17. Paulus W, Baur I, Dours-Zimmermann MT, et al. Differential expression of versican isoforms in brain tumors. J Neuropathol Exp Neurol. 1996;55(5):528-533.
18. Ricciardelli C, Brooks JH, Suwiwat S, et al. Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer. Clin Cancer Res. 2002;8(4):1054-1060.
19. Ween MP, Oehler MK, Ricciardelli C. Role of versican, hyaluronan and CD44 in ovarian cancer metastasis. Int J Mol Sci. 2011; 12(2):1009-1029.
20. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 1999;11(4):443-451.
21. LeBaron RG, Zimmermann DR, Ruoslahti E. Hyaluronate binding properties of versican. J Biol Chem. 1992;267(14):10003-10010.
22. Ricciardelli C, Russell DL, Ween MP, et al. Formation of hyaluronan-and versican-rich pericellular matrix by prostate cancer cells promotes cell motility. J Biol Chem. 2007;282(14):10814-10825.
23. Schmitt CA, Rosenthal CT, Lowe SW. Genetic analysis of chemoresistance in primary murine lymphomas. Nat Med. 2000; 6(9):1029-1035.
24. Jung M, Crang AJ, Blakemore WF, et al. In vitro and in vivo characterisation of glial cells immortalised with a temperature sensitive SV40 T antigen-containing retrovirus. J Neurosci Res. 1994;37(2):182-196.
25. Karlmark KR, Tacke F, Dunay IR. Monocytes in health and disease-Minireview. Eur J Microbiol Immunol. 2012;2(2):97-102.
26. Tye H, Kennedy CL, Najdovska M, et al. STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation. Cancer Cell. 2012;22(4):466-478.
27. Daginakatte GC, Gutmann DH. Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth. Hum Mol Genet. 2007;16(9):1098-1112.
28. Pyonteck SM, Akkari L, Schuhmacher AJ, et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med. 2013;19(10):1264-1272.
29. Pong WW, Higer SB, Gianino SM, et al. Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation. Ann Neurol. 2013;73(2):303-308.
30. Hussain SF, Yang D, Suki D, et al. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro-Oncol. 2006;8(3):261-279.
31. Li D, Wang X, Wu JL, et al. Tumor-produced versican V1 enhances hCAP18/LL-37 expression in macrophages throug activation of TLR2 and vitamin D3 signaling to promote ovarian cancer progression in vitro. PloS One. 2013;8(2):e56616.
32. Curtin JF, Liu N, Candolfi M, et al. HMGB1 mediates endogenous TLR2 activation and brain tumor regression. PLoS Med. 2009; 6(1):e10.
33. Farrar CA, Keogh B, McCormack W, et al. Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury. FASEB J. 2012;26(2):799-807.
34. Reilly M, Miller RM, Thomson MH, et al. Randomized, double-blind, placebo-controlled, dose-escalating phase I, healthy subjects study of intravenous OPN-305, a humanized anti-TLR2 antibody. Clin Pharmacol Ther. 2013;94(5):593-600.
35. Kreisl TN, Kim L, Moore K, et al. Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol. 2009;27(5): 740-745.